Cannonau Corp. (CNNC)
Cannonau Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Skaneateles, NY, US. The stock last traded at $0.00, down 33.33% on the session, giving a market capitalisation of $48,275. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 0.0%. Its beta of 2.11 implies it has historically moved more than the broad market.
Cannonau Corp. specializes in the development and marketing of products based on cannabidiol. The company, which was established in 2007, previously operated as Pacific Blue Energy Corp. before officially rebranding to Cannonau Corp. in August 2019. Its operations are headquartered in Skaneateles, New York.
Cannonau Corp. is most often compared with the following Healthcare names: